Tong Ren Tang Technologies Co. Ltd.

Equities

1666

CNE100000585

Pharmaceuticals

Delayed Hong Kong S.E. 10:58:12 2024-02-29 pm EST 5-day change 1st Jan Change
5.13 HKD -0.19% Intraday chart for Tong Ren Tang Technologies Co. Ltd. -6.90% -21.68%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tong Ren Tang Technologies' 2023 Profit to Slip Up to 7% MT
Tong Ren Tang Technologies Co. Ltd. Provides Earnings Guidance for the Twelve Months Ended 31 December 2023 CI
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
Beijing Tong Ren Tang Appoints Chairman MT
Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Gu Hai Ou as Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Planning Committee CI
Beijing Tong Ren Tang to Vote Dec. 27 on Renewal of Distributorship Contracts MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes New Exclusive Distributorship Framework Agreements CI
Tong Ren Tang Logs 514 Million Yuan in Nine-Month Profit MT
Tong Ren Tang Technologies' Profit Rises 16% in H1 MT
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tong Ren Tang to Log Up to 17% Rise in H1 Profit MT
Tong Ren Tang Technologies Co. Ltd. Provides Revenue Guidance for the Six Months Ended 30 June 2023 CI
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 14 August 2023 CI
Tong Ren Tang Technologies Co. Ltd. Announces Change in Joint Company Secretaries CI
Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2022 CI
Tong Ren Tang Technologies' Profit Jumps 15% in 2022 MT
Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 14 August 2023 CI
Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tong Ren Tang Technologies to Raise Capital in Subsidiary to $4 Million With Other Companies MT
Tong Ren Tang Technologies Co. Ltd. Announces Change of Director CI
Tong Ren Tang Technologies Co. Ltd. Approves the Appointment of Feng Li as A Non-Executive Director CI
Tong Ren Tang Technologies Co. Ltd Announces Resignation of Guo Ya as Director CI
Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart Tong Ren Tang Technologies Co. Ltd.
More charts
Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The Company is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The Company mainly distributes its products in the domestic market and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.721 CNY
Average target price
6.805 CNY
Spread / Average Target
+44.16%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Tong Ren Tang Technologies Co. Ltd. - Hong Kong S.E.
  4. News Tong Ren Tang Technologies Co. Ltd.
  5. Beijing Tong Ren Tang to Vote Dec. 27 on Renewal of Distributorship Contracts
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW